دورية أكاديمية

Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients

التفاصيل البيبلوغرافية
العنوان: Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients
المؤلفون: Mahadevan, D., Mita, Monica, Richards, Donald, McClay, Edward, Heist, Rebecca Suk, Kumar, A., Sundararajan, S., Naing, Aung
المصدر: Cancer Chemotherapy and Pharmacology ; volume 79, issue 4, page 681-688 ; ISSN 0344-5704 1432-0843
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2017
مصطلحات موضوعية: Pharmacology (medical), Cancer Research, Pharmacology, Toxicology, Oncology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1007/s00280-017-3258-0
DOI: 10.1007/s00280-017-3258-0.pdf
DOI: 10.1007/s00280-017-3258-0/fulltext.html
الإتاحة: https://doi.org/10.1007/s00280-017-3258-0Test
حقوق: http://www.springer.com/tdmTest
رقم الانضمام: edsbas.2E9308D7
قاعدة البيانات: BASE